198 related articles for article (PubMed ID: 20404486)
1. Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD.
Amarnath S; Flomerfelt FA; Costanzo CM; Foley JE; Mariotti J; Konecki DM; Gangopadhyay A; Eckhaus M; Wong S; Levine BL; June CH; Fowler DH
Autophagy; 2010 May; 6(4):523-41. PubMed ID: 20404486
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.
Jung U; Foley JE; Erdmann AA; Toda Y; Borenstein T; Mariotti J; Fowler DH
Biol Blood Marrow Transplant; 2006 Sep; 12(9):905-18. PubMed ID: 16920556
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin-resistant effector T-cell therapy.
Fowler DH
Immunol Rev; 2014 Jan; 257(1):210-25. PubMed ID: 24329799
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin resistant murine th9 cells have a stable in vivo phenotype and inhibit graft-versus-host reactivity.
Mangus CW; Massey PR; Fowler DH; Amarnath S
PLoS One; 2013; 8(8):e72305. PubMed ID: 23991087
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
[TBL] [Abstract][Full Text] [Related]
6. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo.
Erdmann AA; Gao ZG; Jung U; Foley J; Borenstein T; Jacobson KA; Fowler DH
Blood; 2005 Jun; 105(12):4707-14. PubMed ID: 15746085
[TBL] [Abstract][Full Text] [Related]
7. Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells.
Hu H; Chai Y; Wang L; Zhang J; Lee HJ; Kim SH; Lü J
Mol Cancer Ther; 2009 Oct; 8(10):2833-43. PubMed ID: 19825802
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells.
Liu Y; Liu JH; Chai K; Tashiro S; Onodera S; Ikejima T
J Pharm Pharmacol; 2013 Nov; 65(11):1622-42. PubMed ID: 24102522
[TBL] [Abstract][Full Text] [Related]
9. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells.
Zhang H; Kong X; Kang J; Su J; Li Y; Zhong J; Sun L
Toxicol Sci; 2009 Aug; 110(2):376-88. PubMed ID: 19451193
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of ras and changes of mitochondrial membrane potential contribute to oridonin-induced autophagy in a431 cells.
Li D; Cui Q; Chen SG; Wu LJ; Tashiro S; Onodera S; Ikejima T
J Pharmacol Sci; 2007 Sep; 105(1):22-33. PubMed ID: 17895587
[TBL] [Abstract][Full Text] [Related]
12. BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells.
Sharma A; Singh K; Mazumder S; Hill BT; Kalaycio M; Almasan A
Cell Death Dis; 2013 May; 4(5):e628. PubMed ID: 23681223
[TBL] [Abstract][Full Text] [Related]
13. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells.
Singh BN; Kumar D; Shankar S; Srivastava RK
Biochem Pharmacol; 2012 Nov; 84(9):1154-63. PubMed ID: 22902833
[TBL] [Abstract][Full Text] [Related]
14. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
Krenger W; Snyder KM; Byon JC; Falzarano G; Ferrara JL
J Immunol; 1995 Jul; 155(2):585-93. PubMed ID: 7608537
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients.
Gigante M; Mandic M; Wesa AK; Cavalcanti E; Dambrosio M; Mancini V; Battaglia M; Gesualdo L; Storkus WJ; Ranieri E
J Immunother; 2008 Apr; 31(3):254-62. PubMed ID: 18317362
[TBL] [Abstract][Full Text] [Related]
16. Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells.
Wang KF; Yang H; Jiang WQ; Li S; Cai YC
Int J Mol Med; 2015 Dec; 36(6):1556-62. PubMed ID: 26499488
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin Activating Enzyme UBA6 Regulates Th1 and Tc1 Cell Differentiation.
Lee JY; An EK; Hwang J; Jin JO; Lee PCW
Cells; 2021 Dec; 11(1):. PubMed ID: 35011668
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin treatment increases hippocampal cell viability in an mTOR-independent manner during exposure to hypoxia mimetic, cobalt chloride.
Zimmerman MA; Biggers CD; Li PA
BMC Neurosci; 2018 Dec; 19(1):82. PubMed ID: 30594149
[TBL] [Abstract][Full Text] [Related]
19. CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexes.
Huang H; Hao S; Li F; Ye Z; Yang J; Xiang J
Immunology; 2007 Feb; 120(2):148-59. PubMed ID: 17274112
[TBL] [Abstract][Full Text] [Related]
20. Proviral integration site for Moloney murine leukemia virus (PIM) kinases promote human T helper 1 cell differentiation.
Tahvanainen J; Kyläniemi MK; Kanduri K; Gupta B; Lähteenmäki H; Kallonen T; Rajavuori A; Rasool O; Koskinen PJ; Rao KV; Lähdesmäki H; Lahesmaa R
J Biol Chem; 2013 Feb; 288(5):3048-58. PubMed ID: 23209281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
